Debio 1347
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Debio 1347, covering 2022-11-25 to 2022-11-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]